Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-29T13:19:04.440Z Has data issue: false hasContentIssue false

Somatic symptoms and high-sensitive C-reactive protein in major depression

Published online by Cambridge University Press:  16 April 2020

G. Camardese
Affiliation:
Institute of Psychiatry, Catholic University, Rome, Italy
G. Pizi
Affiliation:
Institute of Psychiatry, Catholic University, Rome, Italy
B. Leone
Affiliation:
Institute of Psychiatry, Catholic University, Rome, Italy
L. De Risio
Affiliation:
Institute of Psychiatry, Catholic University, Rome, Italy
B. Mattioli
Affiliation:
Institute of Psychiatry, Catholic University, Rome, Italy
R. Serrani
Affiliation:
Institute of Psychiatry, Catholic University, Rome, Italy
P. Bria
Affiliation:
Institute of Psychiatry, Catholic University, Rome, Italy
L. Janiri
Affiliation:
Institute of Psychiatry, Catholic University, Rome, Italy

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Aim

High-sensitive C-reactive protein (hs-CRP) has been used to assess low-grade immune system activation. In a population-based cohort hs-CRP was associated with functional somatic symptoms (SS), particularly with general and musculoskeletal functional SS clusters.

Immune system dysregulation has also been reported in depression that is frequently associated to a high burden of SS.

We investigated the correlation between hs-PCR and SS in depressed patients.

Methods

123 outpatients (M/F = 58/65; mean age 48,6 ± 14,8) during a Major Depressive Episode were recruited at the Institute of Psychiatry of the Catholic University in Rome. Severity of depression was assessed with the HAM-D scale. The somatization factor of the HAM-D (somatic anxiety, gastrointestinal symptoms, general somatic symptoms, hypochondria, weight loss) measured SS burden. A blood sample was collected to determine hs-CRP.

Results

Hs-CRP and depression severity were not correlated, while hs-CRP and SS were (r = -0,27; p = 0,001). Patients with higher (> 3) somatizazion factor had significantly lower hs-PCR values compared to patients with lower (≤3) somatization factor (2,47 mg/L ± 4.77 vs. 3.20 mg/L ± 4.44; p = 0,026).

Conclusions

In contrast with the hypothesized cytokine involvement in somatic features of sickness behavior, higher somatic burden correlates with lower immune activation.

The role of sickness behavior in experiencing SS and hs-CRP's use as valid indicator of cytokine production remain uncertain. Further studies are necessary, also to explore the relationship between HPA axis dysregulation and immune activation, possibly relevant to the interpretation of our results.

Type
P02-21
Copyright
Copyright © European Psychiatric Association 2011
Submit a response

Comments

No Comments have been published for this article.